[English] 日本語
Yorodumi- PDB-4dtg: Hemostatic effect of a monoclonal antibody mAb 2021 blocking the ... -
+Open data
-Basic information
Entry | Database: PDB / ID: 4dtg | ||||||
---|---|---|---|---|---|---|---|
Title | Hemostatic effect of a monoclonal antibody mAb 2021 blocking the interaction between FXa and TFPI in a rabbit hemophilia model | ||||||
Components |
| ||||||
Keywords | BLOOD CLOTTING INHIBITOR/IMMUNE SYSTEM / antibody / inhibitor / blood coagulation / BLOOD CLOTTING INHIBITOR-IMMUNE SYSTEM complex | ||||||
Function / homology | Function and homology information negative regulation of blood coagulation / Extrinsic Pathway of Fibrin Clot Formation / cellular response to steroid hormone stimulus / endopeptidase inhibitor activity / side of membrane / serine-type endopeptidase inhibitor activity / caveola / blood coagulation / cell surface / endoplasmic reticulum ...negative regulation of blood coagulation / Extrinsic Pathway of Fibrin Clot Formation / cellular response to steroid hormone stimulus / endopeptidase inhibitor activity / side of membrane / serine-type endopeptidase inhibitor activity / caveola / blood coagulation / cell surface / endoplasmic reticulum / extracellular space / extracellular region / plasma membrane Similarity search - Function | ||||||
Biological species | Homo sapiens (human) | ||||||
Method | X-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 1.8 Å | ||||||
Authors | Svensson, L.A. / Breinholt, J. / Krogh, B.O. / Hilden, I. | ||||||
Citation | Journal: Blood / Year: 2012 Title: Hemostatic effect of a monoclonal antibody mAb 2021 blocking the interaction between FXa and TFPI in a rabbit hemophilia model. Authors: Hilden, I. / Lauritzen, B. / Sorensen, B.B. / Clausen, J.T. / Jespersgaard, C. / Krogh, B.O. / Bowler, A.N. / Breinholt, J. / Gruhler, A. / Svensson, L.A. / Petersen, H.H. / Petersen, L.C. / ...Authors: Hilden, I. / Lauritzen, B. / Sorensen, B.B. / Clausen, J.T. / Jespersgaard, C. / Krogh, B.O. / Bowler, A.N. / Breinholt, J. / Gruhler, A. / Svensson, L.A. / Petersen, H.H. / Petersen, L.C. / Balling, K.W. / Hansen, L. / Hermit, M.B. / Egebjerg, T. / Friederichsen, B. / Ezban, M. / Bjorn, S.E. | ||||||
History |
|
-Structure visualization
Structure viewer | Molecule: MolmilJmol/JSmol |
---|
-Downloads & links
-Download
PDBx/mmCIF format | 4dtg.cif.gz | 221.6 KB | Display | PDBx/mmCIF format |
---|---|---|---|---|
PDB format | pdb4dtg.ent.gz | 178 KB | Display | PDB format |
PDBx/mmJSON format | 4dtg.json.gz | Tree view | PDBx/mmJSON format | |
Others | Other downloads |
-Validation report
Summary document | 4dtg_validation.pdf.gz | 484.6 KB | Display | wwPDB validaton report |
---|---|---|---|---|
Full document | 4dtg_full_validation.pdf.gz | 503.5 KB | Display | |
Data in XML | 4dtg_validation.xml.gz | 29 KB | Display | |
Data in CIF | 4dtg_validation.cif.gz | 41 KB | Display | |
Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/dt/4dtg ftp://data.pdbj.org/pub/pdb/validation_reports/dt/4dtg | HTTPS FTP |
-Related structure data
-Links
-Assembly
Deposited unit |
| ||||||||
---|---|---|---|---|---|---|---|---|---|
1 |
| ||||||||
Unit cell |
|
-Components
-Protein , 1 types, 1 molecules K
#3: Protein | Mass: 7939.789 Da / Num. of mol.: 1 Fragment: Kunitz-type protease inhibitor domain 2 (UNP residues 119-178) Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: LACI, TFPI, TFPI (AMINO ACIDS 119-178), TFPI1 / Production host: Escherichia coli (E. coli) / References: UniProt: P10646 |
---|
-Antibody , 2 types, 2 molecules LH
#1: Antibody | Mass: 23846.619 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) Cell line (production host): Human embryonic kidney 293 cells Production host: Homo sapiens (human) |
---|---|
#2: Antibody | Mass: 23745.414 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) Cell line (production host): Human embryonic kidney 293 cells Production host: Homo sapiens (human) |
-Non-polymers , 4 types, 414 molecules
#4: Chemical | ChemComp-GOL / #5: Chemical | ChemComp-MES / | #6: Chemical | #7: Water | ChemComp-HOH / | |
---|
-Experimental details
-Experiment
Experiment | Method: X-RAY DIFFRACTION / Number of used crystals: 1 |
---|
-Sample preparation
Crystal | Density Matthews: 3.72 Å3/Da / Density % sol: 66.94 % |
---|---|
Crystal grow | Temperature: 295 K / pH: 6 Details: 0.05 M CALCIUM CHLORIDE, 0.1 M MES, pH 6.0, 45% V/V PEG 200, VAPOR DIFFUSION, SITTING DROP, temperature 295K |
-Data collection
Diffraction | Mean temperature: 100 K |
---|---|
Diffraction source | Source: SYNCHROTRON / Site: MAX II / Beamline: I911-3 / Wavelength: 1 |
Detector | Type: MARMOSAIC 225 mm CCD / Detector: CCD / Date: Nov 11, 2009 / Details: TWO MIRRORS |
Radiation | Monochromator: DOUBLE CRYSTAL MONOCHROMATOR, SI(111). THE FIRST CRYSTAL IS WATER COOLED. Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray |
Radiation wavelength | Wavelength: 1 Å / Relative weight: 1 |
Reflection | Resolution: 1.8→30 Å / Num. obs: 76298 / % possible obs: 99 % / Observed criterion σ(I): -3 / Redundancy: 4.8 % / Biso Wilson estimate: 36 Å2 / Rsym value: 0.066 / Net I/σ(I): 12.7 |
Reflection shell | Resolution: 1.8→1.85 Å / Mean I/σ(I) obs: 2 / % possible all: 98.5 |
-Processing
Software |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Refinement | Method to determine structure: MOLECULAR REPLACEMENT Starting model: PDB ENTRIES 1F8T AND 1TFX Resolution: 1.8→29.102 Å / Cor.coef. Fo:Fc: 0.962 / Cor.coef. Fo:Fc free: 0.941 / SU B: 3.451 / SU ML: 0.05 / Cross valid method: THROUGHOUT / ESU R: 0.022 / ESU R Free: 0.023 / Stereochemistry target values: MAXIMUM LIKELIHOOD / Details: HYDROGENS HAVE BEEN USED IF PRESENT IN THE INPUT
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Solvent computation | Ion probe radii: 0.8 Å / Shrinkage radii: 0.8 Å / VDW probe radii: 1.2 Å / Solvent model: MASK | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Displacement parameters | Biso mean: 39.36 Å2
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refinement step | Cycle: LAST / Resolution: 1.8→29.102 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refine LS restraints |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LS refinement shell | Resolution: 1.8→1.85 Å / Total num. of bins used: 20
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refinement TLS params. | Method: refined / Refine-ID: X-RAY DIFFRACTION
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refinement TLS group |
|